Evidence map›Paper›PMID 33737926›Full record

ArticleFrontiers in immunology2021

Framework for Characterizing Longitudinal Antibody Response in Children After

Eric Rogier, Doug Nace, Pedro R Dimbu, Brian Wakeman, Jan Pohl, James G Beeson, Chris Drakeley, Kevin Tetteh, Mateusz Plucinski

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Antibody Responses to the ConservedPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Eric RogierMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Doug NaceMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Pedro R DimbuNational Malaria Control Program, Luanda, Angola.
Brian WakemanMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Jan PohlDivision of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA, United States.
James G BeesonBurnet Institute, Melbourne, VIC, Australia.
Chris DrakeleyLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Kevin TettehLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Mateusz PlucinskiMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Division of Parasitic Diseases and Malaria · USLondon School of Hygiene & Tropical Medicine · GBBurnet Institute · AUCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human

Indexed as

Antibodies, ProtozoanAntigens, ProtozoanChildFemaleHost-Parasite InteractionsHumansImmunoassayImmunoglobulin IsotypesMalaria, FalciparumMalePlasmodium falciparumSeroepidemiologic StudiesAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin Isotypesantibody classesantibody dynamicsantigensmalariaPlasmodium faciparum

Identifiers

PMID33737926
PMCPMC7960919
OpenAlexW3134936059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.